Elicio Therapeutics

Cambridge, United States

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

$100.0M raised

Mar 2026

Post Ipo Equity

Biotechnology Health Care Medical Pharmaceutical Therapeutics

Top Investors

EFung Capital Angion GKCC Thynk Capital Trend Investment Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Elicio Therapeutics

How much funding has Elicio Therapeutics raised?

Elicio Therapeutics has raised $100.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.

Who are Elicio Therapeutics's investors?

Elicio Therapeutics's investors include EFung Capital, Angion, GKCC, Thynk Capital, Trend Investment Group.

Where is Elicio Therapeutics headquartered?

Elicio Therapeutics is headquartered in Cambridge, United States.

What does Elicio Therapeutics do?

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

What stage is Elicio Therapeutics at?

Elicio Therapeutics is at the Post Ipo Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 16, 2026.

MLA

"Elicio Therapeutics — Funding & Investors." VCBacked, March 16, 2026, https://www.vcbacked.co/company/elicio-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Elicio Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/elicio-therapeutics

Wikipedia (cite web)

{{cite web |title=Elicio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/elicio-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 16, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K